Benjamin J. Zeskind, Ph.D.

Benjamin J. Zeskind, Ph.D.

President and Chief Executive OfficeratImmuneering· In proxies 2022–2025

Pay in FY2022Immuneering stock -70.0% the same year

Benjamin J. Zeskind, Ph.D. was paid $2.1M in FY2022 (Dec). Immuneering stock fell 70.0% that year.

Pay$100 in the stock at the end of FY21 → $30
Pay is from the Summary Compensation Table of each Immuneering proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmuneeringPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -78%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?